Silvia Cicconi

Immediate surgery compared with short-course neoadjuvant gemcitabine plus capecitabine, FOLFIRINOX, or chemoradiotherapy in patients with borderline resectable pancreatic cancer (ESPAC5): a four-arm, multicentre, randomised, phase 2 trial

Paula Ghaneh, Daniel H. Palmer, Silvia Cicconi et al. · ˜The œLancet. Gastroenterology & hepatology · 2022 · 294 citations · Full text

Surgical Oncology, Immediate Surgery, Pancreatic Cancer +7

Treatment of MOG-IgG-associated disorder with rituximab: An international study of 121 patients

Daniel Whittam, Álvaro Cobo‐Calvo, A. Sebastian López‐Chiriboga et al. · Multiple Sclerosis and Related Disorders · 2020 · 165 citations · Full text

Moxibustion, Autoimmune Disease, Immunodeficiencies +6

ESPAC-5F: Four-arm, prospective, multicenter, international randomized phase II trial of immediate surgery compared with neoadjuvant gemcitabine plus capecitabine (GEMCAP) or FOLFIRINOX or chemoradiotherapy (CRT) in patients with borderline resectable pancreatic cancer.

Paula Ghaneh, Daniel H. Palmer, Silvia Cicconi et al. · Journal of Clinical Oncology · 2020 · 164 citations

Surgical Oncology, Neoadjuvant Therapy, Cancer Management +17

Glutamine-enriched parenteral nutrition after autologous peripheral blood stem cell transplantation: effects on immune reconstitution and mucositis.

Nicola Piccirillo, Silvia De Matteis, Luca Laurenti et al. · PubMed · 2003 · 73 citations

Parsimonious Eurolung risk models to predict cardiopulmonary morbidity and mortality following anatomic lung resections: an updated analysis from the European Society of Thoracic Surgeons database

Alessandro Brunelli, Silvia Cicconi, Herbert Decaluwé et al. · European Journal of Cardio-Thoracic Surgery · 2019 · 45 citations · Full text